Attachments
Introduction
While this paper was issued in 2004, the content is still of use for identifying considerations associated with purchase and supply of unlicensed medicinal products.
For good clinical reasons the use of unlicensed medicines and the use of licensed medicines for unlicensed indications is widespread in hospitals. Were this practice to be curtailed the treatment of many patients would be impeded. It is therefore important that all prescribers and pharmacists should be aware of the associated medico-legal implications.
Licensed medicinal products are subject to stringent control by the Medicines and Healthcare products Regulatory Agency (MHRA), neither prescriber nor pharmacist can make the same assumptions of quality, safety and efficacy about unlicensed products.
Attachments
Update history
- Third Edition
- Published